NYSE$EPC

Edgewell Personal Care · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Edgewell's financial performance was solid, marked by net sales increase and organic net sales growth.

Edgewell Personal Care announced its first fiscal quarter 2023 results, with net sales of $469.1 million, a 1.3% increase compared to the prior year period, and organic net sales increased by 3.0%. The company maintains its fiscal 2023 outlook for organic net sales and adjusted EPS and EBITDA.

  • Net sales increased by 1.3%, with organic net sales up by 3.0%.
  • GAAP diluted EPS was $0.23, compared to $0.20 in the prior year period.
  • Adjusted EPS was $0.31, inclusive of a $0.05 unfavorable currency impact, compared to $0.42 in the prior year period.
  • The company ended the quarter with $184 million in cash on hand and access to an additional $164 million revolving credit facility.

Headline financials

Total Revenue

$469M

Previous: $463M+1.3%
EPS (adj)

$0.31

Previous: $0.42-26.2%
Gross Margin

40.3%

Previous: 41.0%-1.7%
Free Cash Flow

$11.9M

Previous: $11.2M+6.3%
Net Income

$11.9M

Previous: $11.2M+6.3%
Operating Income

$31.3M

Previous: $31.8M-1.6%
Gross Profit

$189M

Previous: $190M-0.5%
Cash & Equivalents

$184M

Previous: $240M-23.2%
Total Assets

$3.8B

Previous: $3.81B-0.3%
Stock-Based Comp

$6.5M

Previous: $5.5M+18.2%

Revenue & EPS history

Edgewell · Revenue · Quarterly

$469M

Q1 2023+1.3%vs Q1 2022
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Edgewell · $388M total across 2 segments · Q1 2023

  • Wet Shave
    $275M-3.8%
  • Sun and Skin Care
    $113M+7.7%

Forward guidance

The Company is providing the following outlook assumptions for fiscal 2023:

Tailwinds

  • Reported net sales expected to increase in the range of 2% to 4%
  • Organic net sales expected to increase in the range of 3% to 5%
  • GAAP EPS expected to be in the range of $1.90 to $2.10
  • Adjusted EPS expected to be in the range of $2.30 to $2.50
  • Gross margin is expected to increase approximately 30-basis points, with margin accretion expected in the second half of the fiscal year

Headwinds

  • Includes an estimated 150-basis point negative impact from currency translation
  • Includes: Restructuring charges, acquisition and integration costs and Sun Care reformulation costs
  • Includes an estimated $30 million, or $0.45 EPS unfavorable impact from foreign currency changes
  • Operating margin is expected to increase slightly
  • Interest expense is expected to be approximately $79 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

+0.2%

Avg return

Earnings day

+0.1%

Avg return

5 days after

-0.8%

Avg return

30 days after

56%

38 / 68 earnings

Positive

+20.1%

Q1 2020

Best reaction

-17.0%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+2.2%-13.9%-13.1%
Q1 2026-4.6%+5.5%-4.0%
Q4 2025-2.7%-10.8%-8.0%
Q2 2025-10.2%-4.3%-9.9%
Q1 2025-9.5%-5.8%-2.5%
Q4 2024-0.5%-2.8%+1.1%
Q3 2024-0.2%-0.7%+5.8%
Q2 2024+4.4%+7.9%+3.4%
Q1 2024+5.6%+6.6%+2.8%
Q4 2023-2.5%+1.6%-0.7%
Q3 2023-2.8%-2.1%-2.1%
Q2 2023+1.9%+2.6%-2.0%
Q1 2023+4.7%+5.7%-3.8%
Q4 2022+0.9%+2.8%+3.5%
Q3 2022+2.6%+4.0%-3.9%
Q2 2022-11.8%-10.6%-8.8%
Q1 2022-11.0%-15.1%-17.0%
Q4 2021+13.9%+14.6%+17.2%
Q3 2021+8.0%+8.8%+0.6%
Q2 2021+9.1%+10.4%+13.2%
Q1 2021+0.6%-2.7%+1.5%
Q4 2020+9.2%+13.2%+12.1%
Q3 2020-7.8%-5.0%-1.0%
Q2 2020+11.1%+2.7%+22.6%
Q1 2020+20.1%+10.4%-2.1%
Q4 2019-11.4%-15.5%-13.2%
Q3 2019+7.5%+2.2%+2.8%
Q2 2019-17.0%-15.1%-22.8%
Q1 2019+6.6%+10.0%+9.1%
Q4 2018-9.6%-6.1%-11.6%
Q3 2018+2.8%+2.4%-1.3%
Q2 2018-1.4%+2.2%+5.1%
Q1 2018-4.5%-4.4%+0.8%
Q4 2017-6.5%-5.1%-2.8%
Q3 2017+2.5%+3.3%+2.2%
Q2 2017+5.4%+3.6%+3.5%
Q1 2017-1.4%-1.7%-2.4%
Q4 2016+8.2%+8.7%+1.7%
Q3 2016-5.4%-2.9%-5.9%
Q2 2016-3.7%
Q1 2016-0.2%
Q4 2015-3.0%
Q3 2015+0.4%
Q2 2015+0.9%
Q1 2015-1.6%
Q4 2014-0.0%
Q3 2014-0.3%
Q2 2014+3.6%
Q1 2014-0.6%
Q4 2013+1.4%
Q3 2013-2.5%
Q2 2013+3.8%
Q1 2013+2.8%
Q4 2012+0.0%
Q3 2012-13.5%
Q2 2012-2.2%
Q1 2012+2.3%
Q4 2011-1.7%
Q3 2011+1.0%
Q2 2011+0.5%
Q1 2010+0.3%
Q1 2011+0.1%
Q2 2010+1.5%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2009+4.3%
Q3 2010+4.3%
Q4 2009+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro